{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:17:34Z","timestamp":1791231454057,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T00:00:00Z","timestamp":1673481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T00:00:00Z","timestamp":1673481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["OBES SURG"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s11695-022-06437-7","type":"journal-article","created":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T12:08:32Z","timestamp":1673525312000},"page":"725-732","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Intragastric Balloon Significantly Improves Metabolic Parameters at 6 Months: a Meta-Analysis"],"prefix":"10.1007","volume":"33","author":[{"given":"Rahil H.","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyam","family":"Vedantam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shria","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Pearlman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5865-6948","authenticated-orcid":false,"given":"Sean","family":"Bhalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,12]]},"reference":[{"key":"6437_CR1","unstructured":"\u201cAdult obesity facts.\u201d Centers for Disease Control and Prevention, Centers for Disease Control and Prevention, 30 Sept. 2021.\u00a0https:\/\/www.cdc.gov\/obesity\/data\/adult.html. Accessed 11\/1\/2021"},{"key":"6437_CR2","unstructured":"Obesity and overweight. World Health Organization. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/obesity-and-overweight. Published April 1, 2020. Accessed June 23, 2020."},{"issue":"3","key":"6437_CR3","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/joim.12012","volume":"273","author":"L Sj\u00f6str\u00f6m","year":"2013","unstructured":"Sj\u00f6str\u00f6m L. Review of the key results from the Swedish Obese Subjects (SOS) trial \u2013 a prospective controlled intervention study of bariatric surgery. J Intern Med. 2013;273(3):219\u201334. https:\/\/doi.org\/10.1111\/joim.12012.","journal-title":"J Intern Med"},{"issue":"4","key":"6437_CR4","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.soard.2014.12.006","volume":"11","author":"J Ponce","year":"2015","unstructured":"Ponce J, Woodman G, Swain J, et al. The REDUCE pivotal trial: a prospective, randomized controlled pivotal trial of a dual intragastric balloon for the treatment of obesity. Surg Obes Relat Dis. 2015;11(4):874\u201381. https:\/\/doi.org\/10.1016\/j.soard.2014.12.006.","journal-title":"Surg Obes Relat Dis"},{"issue":"7","key":"6437_CR5","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1007\/s11695-020-04558-5","volume":"30","author":"APST Kotinda","year":"2020","unstructured":"Kotinda APST, de Moura DTH, Ribeiro IB, et al. Efficacy of intragastric balloons for weight loss in overweight and obese adults: a systematic review and meta-analysis of randomized controlled trials. Obes Surg. 2020;30(7):2743\u201353. https:\/\/doi.org\/10.1007\/s11695-020-04558-5.","journal-title":"Obes Surg"},{"issue":"9","key":"6437_CR6","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1002\/oby.21555","volume":"24","author":"V G\u00f3mez","year":"2016","unstructured":"G\u00f3mez V, Woodman G, Abu Dayyeh BK. Delayed gastric emptying as a proposed mechanism of action during intragastric balloon therapy: Results of a prospective study. Obesity (Silver Spring). 2016;24(9):1849\u201353. https:\/\/doi.org\/10.1002\/oby.21555.","journal-title":"Obesity (Silver Spring)"},{"issue":"3","key":"6437_CR7","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1007\/s11695-020-05084-0","volume":"31","author":"S Chandan","year":"2021","unstructured":"Chandan S, Mohan BP, Khan SR, et al. Efficacy and safety of intragastric balloon (IGB) in non-alcoholic fatty liver disease (NAFLD): a comprehensive review and meta-analysis. Obes Surg. 2021;31(3):1271\u20139. https:\/\/doi.org\/10.1007\/s11695-020-05084-0.","journal-title":"Obes Surg"},{"issue":"2","key":"6437_CR8","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s11695-021-05772-5","volume":"32","author":"JH Loo","year":"2022","unstructured":"Loo JH, Lim YH, Seah HL, et al. Intragastric balloon as bridging therapy prior to bariatric surgery for patients with severe obesity (BMI \u2265 50 kg\/m2): a systematic review and meta-analysis. Obes Surg. 2022;32(2):489\u2013502. https:\/\/doi.org\/10.1007\/s11695-021-05772-5.","journal-title":"Obes Surg"},{"issue":"11","key":"6437_CR9","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1001\/jama.2017.12984","volume":"318","author":"MSJ Rebecca Voelker","year":"2017","unstructured":"Rebecca Voelker MSJ. Deaths reported after intragastric balloon surgery. JAMA. 2017;318(11):996. https:\/\/doi.org\/10.1001\/jama.2017.12984.","journal-title":"JAMA"},{"key":"6437_CR10","doi-asserted-by":"publisher","unstructured":"Omalu BI, Ives DG, Buhari AM, et al. Death rates and causes of death after bariatric surgery for Pennsylvania residents, 1995 to 2004. Arch Surg. 2007;142(10):923\u20138; discussion 929. https:\/\/doi.org\/10.1001\/archsurg.142.10.923.","DOI":"10.1001\/archsurg.142.10.923."},{"issue":"2","key":"6437_CR11","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1136\/bmjebm-2017-110853","volume":"23","author":"MH Murad","year":"2018","unstructured":"Murad MH, Sultan S, Haffar S, et al. Methodological quality and synthesis of case series and case reports. BMJ Evid Based Med. 2018;23(2):60\u20133. https:\/\/doi.org\/10.1136\/bmjebm-2017-110853.","journal-title":"BMJ Evid Based Med"},{"key":"6437_CR12","unstructured":"\u201cEAG\/A1C conversion calculator.\u201d EAG\/A1C conversion calculator, American Diabetes Association.\u00a0https:\/\/professional.diabetes.org\/diapro\/glucose_calc. Accessed 11\/1\/2021"},{"key":"6437_CR13","unstructured":"Balk EM, Earley A, Patel K, et al. Empirical assessment of within-arm correlation imputation in trials of continuous outcomes [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2012 Nov. Report No.: 12(13)-EHC141-EF."},{"issue":"1","key":"6437_CR14","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1111\/j.1365-2036.2008.03687.x","volume":"28","author":"AO Chan","year":"2008","unstructured":"Chan AO, Chow WS, Lam KF, et al. The effect of intragastric balloon placement on weight loss and type 2 diabetes control. Aliment Pharmacol Ther. 2008;28(1):162\u20134. https:\/\/doi.org\/10.1111\/j.1365-2036.2008.03687.x.","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"6437_CR15","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1007\/s11695-015-1859-4","volume":"26","author":"S Mariani","year":"2016","unstructured":"Mariani S, Fiore D, Persichetti A, et al. Circulating SIRT1 increases after intragastric balloon fat loss in obese patients. Obes Surg. 2016;26(6):1215\u201320. https:\/\/doi.org\/10.1007\/s11695-015-1859-4.","journal-title":"Obes Surg"},{"issue":"4","key":"6437_CR16","doi-asserted-by":"publisher","first-page":"e331","DOI":"10.1016\/j.orcp.2013.07.002","volume":"8","author":"M Takihata","year":"2014","unstructured":"Takihata M, Nakamura A, Aoki K, et al. Comparison of intragastric balloon therapy and intensive lifestyle modification therapy with respect to weight reduction and abdominal fat distribution in super-obese Japanese patients. Obes Res Clin Pract. 2014;8(4):e331-8. https:\/\/doi.org\/10.1016\/j.orcp.2013.07.002.","journal-title":"Obes Res Clin Pract"},{"issue":"1","key":"6437_CR17","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.cgh.2020.04.068","volume":"19","author":"F Bazerbachi","year":"2021","unstructured":"Bazerbachi F, Vargas EJ, Rizk M, et al. Intragastric balloon placement induces significant metabolic and histologic improvement in patients with nonalcoholic steatohepatitis. Clin Gastroenterol Hepatol. 2021;19(1):146-154.e4. https:\/\/doi.org\/10.1016\/j.cgh.2020.04.068.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"8","key":"6437_CR18","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1007\/s11695-009-9879-6","volume":"19","author":"N Crea","year":"2009","unstructured":"Crea N, Pata G, Della Casa D, et al. Improvement of metabolic syndrome following intragastric balloon: 1 year follow-up analysis. Obes Surg. 2009;19(8):1084\u20138. https:\/\/doi.org\/10.1007\/s11695-009-9879-6.","journal-title":"Obes Surg"},{"issue":"2","key":"6437_CR19","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/BF03345708","volume":"32","author":"F Donadio","year":"2009","unstructured":"Donadio F, Sburlati LF, Masserini B, et al. Metabolic parameters after BioEnterics intragastric balloon placement in obese patients. J Endocrinol Invest. 2009;32(2):165\u20138. https:\/\/doi.org\/10.1007\/BF03345708.","journal-title":"J Endocrinol Invest"},{"issue":"6","key":"6437_CR20","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.gie.2009.06.036","volume":"71","author":"R Forlano","year":"2010","unstructured":"Forlano R, Ippolito AM, Iacobellis A, et al. Effect of the BioEnterics intragastric balloon on weight, insulin resistance, and liver steatosis in obese patients. Gastrointest Endosc. 2010;71(6):927\u201333. https:\/\/doi.org\/10.1016\/j.gie.2009.06.036.","journal-title":"Gastrointest Endosc"},{"issue":"5","key":"6437_CR21","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1159\/000431177","volume":"24","author":"F Koc","year":"2015","unstructured":"Koc F, Kayaoglu HA, Celik A, et al. Effect of weight loss induced by intragastric balloon therapy on cardiac function in morbidly obese individuals: a pilot study. Med Princ Pract. 2015;24(5):432\u20135. https:\/\/doi.org\/10.1159\/000431177.","journal-title":"Med Princ Pract"},{"issue":"2","key":"6437_CR22","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1007\/s11695-013-1061-5","volume":"24","author":"TT Mafort","year":"2014","unstructured":"Mafort TT, Madeira E, Madeira M, et al. Six-month intragastric balloon treatment for obesity improves lung function, body composition, and metabolic syndrome. Obes Surg. 2014;24(2):232\u201340. https:\/\/doi.org\/10.1007\/s11695-013-1061-5.","journal-title":"Obes Surg"},{"issue":"2","key":"6437_CR23","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s12020-013-0069-x","volume":"45","author":"G Miro\u0161evi\u0107","year":"2014","unstructured":"Miro\u0161evi\u0107 G, Nikoli\u0107 M, Kruljac I, et al. Decrease in insulin resistance has a key role in improvement of metabolic profile during intragastric balloon treatment. Endocrine. 2014;45(2):331\u20134. https:\/\/doi.org\/10.1007\/s12020-013-0069-x.","journal-title":"Endocrine"},{"issue":"8","key":"6437_CR24","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1007\/s11695-008-9766-6","volume":"20","author":"WL Mui","year":"2010","unstructured":"Mui WL, Ng EK, Tsung BY, et al. Impact on obesity-related illnesses and quality of life following intragastric balloon. Obes Surg. 2010;20(8):1128\u201332. https:\/\/doi.org\/10.1007\/s11695-008-9766-6.","journal-title":"Obes Surg"},{"issue":"8","key":"6437_CR25","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1007\/s11695-010-0101-7","volume":"21","author":"M Nikolic","year":"2011","unstructured":"Nikolic M, Mirosevic G, Ljubicic N, et al. Obesity treatment using a Bioenterics intragastric balloon (BIB)\u2013preliminary Croatian results. Obes Surg. 2011;21(8):1305\u201310. https:\/\/doi.org\/10.1007\/s11695-010-0101-7.","journal-title":"Obes Surg"},{"issue":"21","key":"6437_CR26","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.2169\/internalmedicine.50.5672","volume":"50","author":"Y Sekino","year":"2011","unstructured":"Sekino Y, Imajo K, Sakai E, et al. Time-course of changes of visceral fat area, liver volume and liver fat area during intragastric balloon therapy in Japanese super-obese patients. Intern Med. 2011;50(21):2449\u201355. https:\/\/doi.org\/10.2169\/internalmedicine.50.5672.","journal-title":"Intern Med"},{"issue":"5","key":"6437_CR27","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s11695-010-0310-0","volume":"21","author":"D Stimac","year":"2011","unstructured":"Stimac D, Majanovi\u0107 SK, Turk T, et al. Intragastric balloon treatment for obesity: results of a large single center prospective study. Obes Surg. 2011;21(5):551\u20135. https:\/\/doi.org\/10.1007\/s11695-010-0310-0.","journal-title":"Obes Surg"},{"issue":"7","key":"6437_CR28","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.cgh.2018.01.046","volume":"16","author":"EJ Vargas","year":"2018","unstructured":"Vargas EJ, Pesta CM, Bali A, et al. Single fluid-filled intragastric balloon safe and effective for inducing weight loss in a real-world population. Clin Gastroenterol Hepatol. 2018;16(7):1073-1080.e1. https:\/\/doi.org\/10.1016\/j.cgh.2018.01.046.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"7","key":"6437_CR29","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.cgh.2018.02.026","volume":"16","author":"A Agnihotri","year":"2018","unstructured":"Agnihotri A, Xie A, Bartalos C, et al. Real-world safety and efficacy of fluid-filled dual intragastric balloon for weight loss. Clin Gastroenterol Hepatol. 2018;16(7):1081-1088.e1. https:\/\/doi.org\/10.1016\/j.cgh.2018.02.026.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"9","key":"6437_CR30","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1007\/s11695-008-9654-0","volume":"20","author":"K Al Kahtani","year":"2010","unstructured":"Al Kahtani K, Khan MQ, Helmy A, et al. Bio-enteric intragastric balloon in obese patients: a retrospective analysis of King Faisal Specialist Hospital experience. Obes Surg. 2010;20(9):1219\u201326. https:\/\/doi.org\/10.1007\/s11695-008-9654-0.","journal-title":"Obes Surg"},{"key":"6437_CR31","doi-asserted-by":"publisher","unstructured":"Siebenhofer A, Winterholer S, Jeitler K, et al. Long-term effects of weight-reducing drugs in people with hypertension. Cochrane Database Syst Rev. 2021;1(1):CD007654. Published 2021 Jan 17. https:\/\/doi.org\/10.1002\/14651858.CD007654.pub5","DOI":"10.1002\/14651858.CD007654.pub5"},{"key":"6437_CR32","doi-asserted-by":"publisher","unstructured":"Blood pressure lowering treatment trialists\u2019 collaboration. Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis [published correction appears in Lancet. 2021;397(10288):1884]. Lancet. 2021;397(10285):1625\u20131636. https:\/\/doi.org\/10.1016\/S0140-6736(21)00590-0","DOI":"10.1016\/S0140-6736(21)00590-0"},{"issue":"9","key":"6437_CR33","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1016\/j.numecd.2021.05.023","volume":"31","author":"E Capristo","year":"2021","unstructured":"Capristo E, Maione A, Lucisano G, et al. Effects of weight loss medications on mortality and cardiovascular events: a systematic review of randomized controlled trials in adults with overweight and obesity. Nutr Metab Cardiovasc Dis. 2021;31(9):2587\u201395. https:\/\/doi.org\/10.1016\/j.numecd.2021.05.023.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"6437_CR34","doi-asserted-by":"publisher","unstructured":"Prospective Studies Collaboration, Lewington S, Whitlock G, et al. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths [published correction appears in Lancet. 2008;372(9635):292].\u00a0Lancet. 2007;370(9602):1829\u20131839. https:\/\/doi.org\/10.1016\/S0140-6736(07)61778-4","DOI":"10.1016\/S0140-6736(07)61778-4"},{"issue":"9","key":"6437_CR35","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1016\/j.numecd.2021.05.010","volume":"31","author":"M Monami","year":"2021","unstructured":"Monami M, Candido R, Pintaudi B, et al. Improvement of glycemic control in type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Nutr Metab Cardiovasc Dis. 2021;31(9):2539\u201346. https:\/\/doi.org\/10.1016\/j.numecd.2021.05.010.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"4","key":"6437_CR36","doi-asserted-by":"publisher","first-page":"278","DOI":"10.7326\/M20-0864","volume":"173","author":"A Tsapas","year":"2020","unstructured":"Tsapas A, Avgerinos I, Karagiannis T, et al. Comparative effectiveness of glucose-lowering drugs for type 2 diabetes: a systematic review and network meta-analysis. Ann Intern Med. 2020;173(4):278\u201386. https:\/\/doi.org\/10.7326\/M20-0864.","journal-title":"Ann Intern Med"},{"key":"6437_CR37","doi-asserted-by":"publisher","unstructured":"Maiorino MI, Longo M, Scappaticcio L, et al. Improvement of glycemic control and reduction of major cardiovascular events in 18 cardiovascular outcome trials: an updated meta-regression. Cardiovasc Diabetol. 2021;20(1):210. Published 2021 Oct 18. https:\/\/doi.org\/10.1186\/s12933-021-01401-8.","DOI":"10.1186\/s12933-021-01401-8."},{"key":"6437_CR38","doi-asserted-by":"publisher","unstructured":"Cavero-Redondo I, Peleteiro B, \u00c1lvarez-Bueno C, et al. Glycated haemoglobin A1c as a risk factor of cardiovascular outcomes and all-cause mortality in diabetic and non-diabetic populations: a systematic review and meta-analysis. BMJ Open. 2017;7(7):e015949. Published 2017 Jul 31. https:\/\/doi.org\/10.1136\/bmjopen-2017-015949.","DOI":"10.1136\/bmjopen-2017-015949."},{"issue":"11","key":"6437_CR39","doi-asserted-by":"publisher","first-page":"107704","DOI":"10.1016\/j.jdiacomp.2020.107704","volume":"34","author":"M Fralick","year":"2020","unstructured":"Fralick M, Colacci M, Odutayo A, et al. Lowering of hemoglobin A1C and risk of cardiovascular outcomes and all-cause mortality, a meta-regression analysis. J Diabetes Complicat. 2020;34(11):107704. https:\/\/doi.org\/10.1016\/j.jdiacomp.2020.107704.","journal-title":"J Diabetes Complicat"},{"issue":"8","key":"6437_CR40","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.2337\/dc09-1727","volume":"33","author":"D Sherifali","year":"2010","unstructured":"Sherifali D, Nerenberg K, Pullenayegum E, et al. The effect of oral antidiabetic agents on A1C levels: a systematic review and meta-analysis. Diabetes Care. 2010;33(8):1859\u201364. https:\/\/doi.org\/10.2337\/dc09-1727.","journal-title":"Diabetes Care"},{"issue":"3","key":"6437_CR41","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/ajg.2016.530","volume":"112","author":"VB Popov","year":"2017","unstructured":"Popov VB, Ou A, Schulman AR, et al. The impact of intragastric balloons on obesity-related co-morbidities: a systematic review and meta-analysis. Am J Gastroenterol. 2017;112(3):429\u201339. https:\/\/doi.org\/10.1038\/ajg.2016.530.","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"6437_CR42","doi-asserted-by":"publisher","first-page":"815","DOI":"10.4254\/wjh.v13.i7.815","volume":"13","author":"JR de Freitas J\u00fanior","year":"2021","unstructured":"de Freitas J\u00fanior JR, Ribeiro IB, de Moura DTH, et al. Effects of intragastric balloon placement in metabolic dysfunction-associated fatty liver disease: A systematic review and meta-analysis. World J Hepatol. 2021;13(7):815\u201329. https:\/\/doi.org\/10.4254\/wjh.v13.i7.815.","journal-title":"World J Hepatol"},{"key":"6437_CR43","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/1471-2288-8-79","volume":"8","author":"G Rucker","year":"2008","unstructured":"Rucker G, Schwarzer G, Carpenter JR, et al. Undue reliance on I(2) in assessing heterogeneity may mislead. BMC Med Res Methodol. 2008;8:79.","journal-title":"BMC Med Res Methodol"},{"key":"6437_CR44","first-page":"A290","volume":"57","author":"E Machytka","year":"2007","unstructured":"Machytka E, Klvana P, Hanuskova I, et al. Use of pharmacotherapy for long-term maintenance of weight loss following explantation of intragastric balloon (BIB). Gut. 2007;57:A290.","journal-title":"Gut"},{"issue":"4","key":"6437_CR45","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s11695-011-0514-y","volume":"22","author":"MG Farina","year":"2012","unstructured":"Farina MG, Baratta R, Nigro A, et al. Intragastric balloon in association with lifestyle and\/or pharmacotherapy in the long-term management of obesity. Obes Surg. 2012r;22(4):565\u201371. https:\/\/doi.org\/10.1007\/s11695-011-0514-y.","journal-title":"Obes Surg"}],"container-title":["Obesity Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-022-06437-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11695-022-06437-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-022-06437-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T15:17:02Z","timestamp":1678115822000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11695-022-06437-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,12]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["6437"],"URL":"https:\/\/doi.org\/10.1007\/s11695-022-06437-7","relation":{},"ISSN":["0960-8923","1708-0428"],"issn-type":[{"value":"0960-8923","type":"print"},{"value":"1708-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,12]]},"assertion":[{"value":"21 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All \nprocedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study, formal consent is not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Informed consent does not apply.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"Sunil Amin is a consultant for Boston Scientific and MicroTech. However, no grant or outside funding was used for this project. The other authors (RHS, SV, SK, MP, SB) declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}